Another caveat in the use of TS expression is that although low TS has been predictive of response in metastatic colorectal cancer patients, the opposite has been found in patients with Stage II and Stage III disease on adjuvant therapy [90,91,92]. The gene discussed is TYMS; the disease is metastatic colorectal cancer.